Literature DB >> 15033227

Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis.

Melinda J Barker1, Kenneth M Greenwood, Martin Jackson, Simon F Crowe.   

Abstract

Despite the widespread prescribing of benzodiazepines, uncertainty still surrounds the potential for cognitive impairment following their long-term use. Furthermore, the degree of recovery that may take place after withdrawal or the level of residual impairment, if any, that is maintained in long-term benzodiazepine users is also unclear. The current paper employed meta-analytic techniques to address two questions: (1) Does the cognitive function of long-term benzodiazepine users improve following withdrawal? (2) Are previous long-term benzodiazepine users still impaired at follow-up compared to controls or normative data? Results of the meta-analyses indicated that long-term benzodiazepine users do show recovery of function in many areas after withdrawal. However, there remains a significant impairment in most areas of cognition in comparison to controls or normative data. The findings of this study highlight the problems associated with long-term benzodiazepine therapy and suggest that previous benzodiazepine users would be likely to experience the benefit of improved cognitive functioning after withdrawal. However, the reviewed data did not support full restitution of function, at least in the first 6 months following cessation and suggest that there may be some permanent deficits or deficits that take longer than 6 months to completely recover.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033227     DOI: 10.1016/S0887-6177(03)00096-9

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  69 in total

Review 1.  Neuropsychiatric effects of prescription drug abuse.

Authors:  Jason P Caplan; Lucy A Epstein; Davin K Quinn; Jonathan R Stevens; Theodore A Stern
Journal:  Neuropsychol Rev       Date:  2007-08-16       Impact factor: 7.444

Review 2.  The effects of fall-risk-increasing drugs on postural control: a literature review.

Authors:  Maartje H de Groot; Jos P C M van Campen; Marije A Moek; Linda R Tulner; Jos H Beijnen; Claudine J C Lamoth
Journal:  Drugs Aging       Date:  2013-11       Impact factor: 3.923

Review 3.  A Review of Alprazolam Use, Misuse, and Withdrawal.

Authors:  Nassima Ait-Daoud; Allan Scott Hamby; Sana Sharma; Derek Blevins
Journal:  J Addict Med       Date:  2018 Jan/Feb       Impact factor: 3.702

4.  The Relationship between Sleep Complaints, Depression, and Executive Functions on Older Adults.

Authors:  Katie M de Almondes; Mônica V Costa; Leandro F Malloy-Diniz; Breno S Diniz
Journal:  Front Psychol       Date:  2016-10-07

5.  Safety of psychotropic medicines: contribution from observational evidence.

Authors:  H Verdoux
Journal:  Epidemiol Psychiatr Sci       Date:  2018-05-30       Impact factor: 6.892

6.  Multifocal cognitive dysfunction in high-dose benzodiazepine users: a cross-sectional study.

Authors:  Angela Federico; Stefano Tamburin; Alice Maier; Marco Faccini; Rebecca Casari; Laura Morbioli; Fabio Lugoboni
Journal:  Neurol Sci       Date:  2016-10-11       Impact factor: 3.307

7.  Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized clinical trial of add-on melatonin versus placebo.

Authors:  Lone Baandrup; Birgitte Fagerlund; Birte Glenthoj
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-07-11       Impact factor: 5.270

8.  The Role of Benzodiazepines in the Treatment of Epilepsy.

Authors:  Juan G Ochoa; William A Kilgo
Journal:  Curr Treat Options Neurol       Date:  2016-04       Impact factor: 3.598

Review 9.  Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management.

Authors:  Michael J Maher; Simon A Rego; Gregory M Asnis
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

10.  Increasing availability of benzodiazepines among people who inject drugs in a Canadian setting.

Authors:  Geoffrey Walton; Huiru Dong; M J Milloy; Kora DeBeck; Thomas Kerr; Evan Wood; Kanna Hayashi
Journal:  Subst Abus       Date:  2017-09-18       Impact factor: 3.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.